Companies: 10,795·Total market cap: $144.5T
Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.

MISTNASDAQHealthcare● Active
$1.23
+$0.00(+0.00%)
Market Cap$105643332
P/E Ratio—
52W High$3.06
52W Low$1
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Milestone Pharmaceuticals Inc. (MIST) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001408443 · MIST · NASDAQ · as of Jun 8, 2026

Filing snapshot

406
Total Filings
EFFECT
Latest Form
2026-05-22
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001408443 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-20
Fiscal Year End
Mar 20, 2026
Accession No.
0001104659-26-032415
Primary Document
mist-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001408443 · Accession 0001104659-26-032415

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
FORM 8-K
2026-05-13Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2026-05-22
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
S-3Shelf Registration
S-3
2026-05-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
8-KCurrent Report
FORM 8-K
2026-05-13
View
10-QQuarterly Report
10-Q
2026-05-13
View
ARSARS
ARS
2026-04-30
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-30
View
DEF 14AProxy Statement
FORM DEF 14A
2026-04-30
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-23
View
8-KCurrent Report
FORM 8-K
2026-03-20
View
10-KAnnual Report
10-K
2026-03-20
View
8-KCurrent Report
FORM 8-K
2026-01-26
View
8-KCurrent Report
FORM 8-K
2026-01-13
View
Showing 1–15 of 278 filingsForm 4 / 144 hidden· 406 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001408443  |  Exchange: NASDAQ · Healthcare

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) has submitted 406 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001408443, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Milestone Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Milestone Pharmaceuticals Inc. 10-K was filed on 2026-03-20 for fiscal year ending 2026. Historical MIST 10-K annual reports are available from 2007 through 2026.

Investors researching Milestone Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
CYBN SEC Filings →ELTX SEC Filings →IPHA SEC Filings →MOLN SEC Filings →CRDF SEC Filings →CRBP SEC Filings →PEPG SEC Filings →SAVA SEC Filings →
→ MIST Financials→ MIST Earnings→ MIST Insider Trades

Frequently Asked Questions

MIST SEC Filings · 8 questions

Milestone Pharmaceuticals Inc. (MIST) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 406 filings and access original documents at no cost. Milestone Pharmaceuticals Inc.'s CIK is 0001408443.

MIST SEC filingsMilestone Pharmaceuticals Inc. SEC documentsfind MIST 10-K